VMY-1-103
A novel dansylated analog of purvalanol B, and a CDK inhibitor that inhibits cell cycle progression and proliferation in prostate and breast cancer cells more effectively than purvalanol B.
Product Specifications
CAS Number
1209002-43-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
708.27
Molecular Formula
C34H42ClN9O4S
Notes
Research use only, not for human use.
Receptor
CDK
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
AR51800PU-N 500 µg
Peptidase D / PEPD (1-493, His-tag) Human Protein
Sign In for Pricing
View Details 